Brands
Durex finds the other G-spot for early detection
MUMBAI: Who knew pleasure could be a lifesaver? This World Breast Cancer Day, Durex swapped seduction for self-care with its provocative new campaign, The Other G-Spot, proving once again that the world’s most playful brand can also be its most purposeful. The campaign redefines protection by linking the language of pleasure to the power of prevention, urging women to discover a spot that could truly save lives.
For years, pop culture has obsessed over the G-spot, that elusive zone of discovery and delight. Durex, however, has uncovered another, one where “G” stands for “gland”, the mammary glands where most breast cancers begin. And like its better-known namesake, this one too can only be found by touch, by women themselves.
At its heart, the campaign is a call to action, encouraging women to conduct self-examinations, schedule screenings and normalise conversations around early detection. The statistics are sobering, one woman in India is diagnosed with breast cancer every four minutes, yet only a small fraction know how to perform a self-check. Durex wants to change that, one confident conversation at a time.
In the digital film, a woman opens with the teasing line, “I found a new G-Spot, and I can’t wait to show you.” Viewers lean in, expecting a familiar Durex twist, and they get one, just not the kind they anticipated. The reveal? She’s referring to the life-saving self-exam spot.
The campaign cleverly blurs the line between sensuality and self-care, using curiosity to drive awareness. The message lands powerfully, self-touch isn’t just about pleasure, it’s about protection.
But The Other G-Spot isn’t just an ad, it’s an interactive movement. Durex is taking the conversation into private DMs, users who message the brand with “The Other G-Spot” receive a video tutorial guiding them through the art of self-examination, all explained in the familiar, confident Durex tone.
Reckitt South Asia regional marketing director, health Kanika Kalra said, “At Durex, we believe confidence and awareness go hand in hand. This campaign turns prevention into empowerment, encouraging women to see self-care as an act of strength and love.”
With The Other G-Spot, Durex once again pushes boundaries, and this time, they might just save lives doing it. Because real protection, as the brand reminds us, starts long before the bedroom.
Brands
Oyo parent Prism appoints former Sebi chief Ajay Tyagi to Board
Former market regulator joins Prism to strengthen governance for IPO
NEW DELHI: Prism, the parent entity of Oyo, has appointed former Sebi chairman Ajay Tyagi as an independent director, as the hospitality firm gears up for its planned Rs 6,650 crore initial public offering (IPO).
Tyagi, a 1984-batch IAS officer, served as chairman of the Securities and Exchange Board of India (SEBI) from 2017 to 2022. His appointment is aimed at strengthening the company’s governance framework and providing strategic oversight as it moves closer to a public listing.
He joins a high-profile board that already includes several prominent names from global business and policy circles. These include Troy Matthew Alstead, former CFO and group president of Starbucks; Aditya Ghosh, co-founder of Akasa Air; Deepa Malik, paralympic athlete and Padma Shri awardee; William Steve Albrecht, professor of accountancy at Utah State University; and Bejul Somaia, partner at Lightspeed Venture Partners.
Prism founder Ritesh Agarwal, said Tyagi’s experience in capital markets regulation and public-institution stewardship will be critical as the company scales operations and enhances long-term accountability.
The company recently filed preliminary papers with Sebi to raise Rs 6,650 crore through a confidential route. Market sources estimate its valuation will be in the range of $7 billion to $8 billion.
Over the course of his career, Tyagi has held senior roles in the ministry of finance, where he oversaw investment policy and financial-sector reforms. His induction to the Prism board signals a renewed focus on aligning the company’s internal standards with the stringent requirements of public markets as it advances toward its IPO.
